BIONTECH

USPTO USPTO 2010 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark BIONTECH was filed as Word mark on 07/15/2010 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 09/20/2011. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details

Trademark form Word mark
File reference 85085419
Register number 4027807
Application date July 15, 2010
Publication date July 5, 2011
Entry date September 20, 2011

Trademark owner

An der Goldgrube 12
55131 Mainz
DE

Trademark representatives

goods and services

1 Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; Adjuvants for use in manufacture of vaccines; Protein arrays and nucleotide arrays for scientific and medical laboratory use; Nucleic acids, proteins and peptides for laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use
5 Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Vaccines; Adjuvants for medical purposes except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Chemical reagents used for medical or veterinary purposes; Biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; Macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes
42 Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Compiling data for medical and scientific research, clinical trials, and drug admission
44 Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; Veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes

ID: 1385085419